Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice
Abstract. Introduction:. In recent decades, several researches have been conducted in search of new analgesics that do not present the side effects of opioids. In this context, animal venoms contain natural painkillers that have been used for the development of new analgesics. Objective:. The aims o...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2019-12-01
|
| Series: | PAIN Reports |
| Online Access: | http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000000791 |
| _version_ | 1818476559221129216 |
|---|---|
| author | Geissy I.M.C. Feitosa Isabella F. Carvalho Edivaldo B.S. Coelho Marla R.B. Monteiro Rafael L. Medeiros Ellaine D.F. Carvalho Paulo T. A. Silva Dóris M.F. Carvalho Daniel E.A. Uchoa Edilberto R. Silveira Cláudia F. Santos Nilberto R. Nascimento Maria-Denise F. Carvalho Bruno A. Cardi Krishnamurti M. Carvalho |
| author_facet | Geissy I.M.C. Feitosa Isabella F. Carvalho Edivaldo B.S. Coelho Marla R.B. Monteiro Rafael L. Medeiros Ellaine D.F. Carvalho Paulo T. A. Silva Dóris M.F. Carvalho Daniel E.A. Uchoa Edilberto R. Silveira Cláudia F. Santos Nilberto R. Nascimento Maria-Denise F. Carvalho Bruno A. Cardi Krishnamurti M. Carvalho |
| author_sort | Geissy I.M.C. Feitosa |
| collection | DOAJ |
| description | Abstract. Introduction:. In recent decades, several researches have been conducted in search of new analgesics that do not present the side effects of opioids. In this context, animal venoms contain natural painkillers that have been used for the development of new analgesics.
Objective:. The aims of this study were to evaluate the antinociceptive effects of telocinobufagin (TCB), a bufadienolide isolated from Rhinella jimi venom, in murine acute pain models, and to verify the participation of the opioid system in these effects.
Methods:. TCB was purified from R. jimi venom by high-performance liquid chromatography, and its structure was confirmed by spectrometric techniques. TCB was administered intraperitoneally (i.p.) (0.062, 0.125, 0.25, 0.5, and 1 mg·kg−1) and orally (p.o.) (0.625, 1.125, 2.5, 5, and 10 mg·kg−1) in mice, which were then subjected to pain tests: acetic acid–induced writhing, formalin, tail-flick, and hot-plate. Involvement of the opioid system in TCB action was evaluated by naloxone i.p. injected (2.5 mg·kg−1) 20 minutes before TCB administration. In addition, the TCB action on the μ, δ, and κ opioid receptors was performed by radioligand binding assays.
Results:. In all the tests used, TCB showed dose-dependent antinociceptive activity with more than 90% inhibition of the nociceptive responses at the doses of 1 mg·kg−1 (i.p.) and 10 mg·kg−1 (p.o.). Naloxone did not alter the effect of TCB. In addition, TCB did not act on the μ, δ, and κ opioid receptors.
Conclusion:. The results suggest that TCB may represent a novel potential nonopioid therapeutic analgesic for treatment of acute pains. |
| first_indexed | 2024-12-10T09:27:20Z |
| format | Article |
| id | doaj.art-b82e704cf4b143b7af44d5e6b4ae8efd |
| institution | Directory Open Access Journal |
| issn | 2471-2531 |
| language | English |
| last_indexed | 2024-12-10T09:27:20Z |
| publishDate | 2019-12-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | PAIN Reports |
| spelling | doaj.art-b82e704cf4b143b7af44d5e6b4ae8efd2022-12-22T01:54:29ZengWolters KluwerPAIN Reports2471-25312019-12-0146e79110.1097/PR9.0000000000000791201912000-00013Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in miceGeissy I.M.C. Feitosa0Isabella F. Carvalho1Edivaldo B.S. Coelho2Marla R.B. Monteiro3Rafael L. Medeiros4Ellaine D.F. Carvalho5Paulo T. A. Silva6Dóris M.F. Carvalho7Daniel E.A. Uchoa8Edilberto R. Silveira9Cláudia F. Santos10Nilberto R. Nascimento11Maria-Denise F. Carvalho12Bruno A. Cardi13Krishnamurti M. Carvalho14a Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Brazilb Genpharma Consultoria Farmacêutica e Genética LTDA, Fortaleza, Ceará, Brazila Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Brazila Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Brazila Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Brazilb Genpharma Consultoria Farmacêutica e Genética LTDA, Fortaleza, Ceará, Brazilb Genpharma Consultoria Farmacêutica e Genética LTDA, Fortaleza, Ceará, Brazilb Genpharma Consultoria Farmacêutica e Genética LTDA, Fortaleza, Ceará, Brazild Departamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Fortaleza, Ceará, Brazild Departamento de Química Orgânica e Inorgânica, Universidade Federal do Ceará, Fortaleza, Ceará, Brazila Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Brazila Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Brazila Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Brazila Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, Brazila Laboratório de Toxinologia e Farmacologia Molecular, Instituto Superior de Ciências Biomédicas, Universidade Estadual do Ceará, BrazilAbstract. Introduction:. In recent decades, several researches have been conducted in search of new analgesics that do not present the side effects of opioids. In this context, animal venoms contain natural painkillers that have been used for the development of new analgesics. Objective:. The aims of this study were to evaluate the antinociceptive effects of telocinobufagin (TCB), a bufadienolide isolated from Rhinella jimi venom, in murine acute pain models, and to verify the participation of the opioid system in these effects. Methods:. TCB was purified from R. jimi venom by high-performance liquid chromatography, and its structure was confirmed by spectrometric techniques. TCB was administered intraperitoneally (i.p.) (0.062, 0.125, 0.25, 0.5, and 1 mg·kg−1) and orally (p.o.) (0.625, 1.125, 2.5, 5, and 10 mg·kg−1) in mice, which were then subjected to pain tests: acetic acid–induced writhing, formalin, tail-flick, and hot-plate. Involvement of the opioid system in TCB action was evaluated by naloxone i.p. injected (2.5 mg·kg−1) 20 minutes before TCB administration. In addition, the TCB action on the μ, δ, and κ opioid receptors was performed by radioligand binding assays. Results:. In all the tests used, TCB showed dose-dependent antinociceptive activity with more than 90% inhibition of the nociceptive responses at the doses of 1 mg·kg−1 (i.p.) and 10 mg·kg−1 (p.o.). Naloxone did not alter the effect of TCB. In addition, TCB did not act on the μ, δ, and κ opioid receptors. Conclusion:. The results suggest that TCB may represent a novel potential nonopioid therapeutic analgesic for treatment of acute pains.http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000000791 |
| spellingShingle | Geissy I.M.C. Feitosa Isabella F. Carvalho Edivaldo B.S. Coelho Marla R.B. Monteiro Rafael L. Medeiros Ellaine D.F. Carvalho Paulo T. A. Silva Dóris M.F. Carvalho Daniel E.A. Uchoa Edilberto R. Silveira Cláudia F. Santos Nilberto R. Nascimento Maria-Denise F. Carvalho Bruno A. Cardi Krishnamurti M. Carvalho Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice PAIN Reports |
| title | Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice |
| title_full | Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice |
| title_fullStr | Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice |
| title_full_unstemmed | Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice |
| title_short | Potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice |
| title_sort | potent nonopioid antinociceptive activity of telocinobufagin in models of acute pain in mice |
| url | http://journals.lww.com/painrpts/fulltext/10.1097/PR9.0000000000000791 |
| work_keys_str_mv | AT geissyimcfeitosa potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT isabellafcarvalho potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT edivaldobscoelho potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT marlarbmonteiro potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT rafaellmedeiros potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT ellainedfcarvalho potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT paulotasilva potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT dorismfcarvalho potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT danieleauchoa potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT edilbertorsilveira potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT claudiafsantos potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT nilbertornascimento potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT mariadenisefcarvalho potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT brunoacardi potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice AT krishnamurtimcarvalho potentnonopioidantinociceptiveactivityoftelocinobufagininmodelsofacutepaininmice |